4.6 Article

NGS and phenotypic ontology-based approaches increase the diagnostic yield in syndromic retinal diseases

Journal

HUMAN GENETICS
Volume 140, Issue 12, Pages 1665-1678

Publisher

SPRINGER
DOI: 10.1007/s00439-021-02343-7

Keywords

-

Funding

  1. Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Health (FIS) [PI16/00425, PI19/00321]
  2. Centro de Investigacion Biomedica en Red Enfermedades Raras (CIBERER) [06/07/0036]
  3. IIS-FJD BioBank [PT13/0010/0012]
  4. Comunidad de Madrid (CAM, RAREGenomics Project) [B2017/BMD-3721]
  5. European Regional Development Fund (FEDER)
  6. Organizacion Nacional de Ciegos Espanoles (ONCE)
  7. Ramon Areces Foundation [4019/012]
  8. Conchita Rabago Foundation
  9. University Chair UAM-IIS-FJD of Genomic Medicine
  10. ISCIII [FI17/00192]
  11. Comunidad de Madrid (CAM) [PEJ-2017-AI/BMD7256]
  12. Miguel Servet program contract from ISCIII [CP16/00116, CPII17/00006]

Ask authors/readers for more resources

The study aimed to improve clinical and molecular diagnosis of SRDs by applying structured phenotypic ontology and NGS-based pipelines. Ciliopathies were found to be the most common SRD type, with a global characterization rate of 52% and an improved rate of 83% for prospective cases. Some cases were reclassified into a different clinical category after identification of the disease-causing gene.
Syndromic retinal diseases (SRDs) are a group of complex inherited systemic disorders, with challenging molecular underpinnings and clinical management. Our main goal is to improve clinical and molecular SRDs diagnosis, by applying a structured phenotypic ontology and next-generation sequencing (NGS)-based pipelines. A prospective and retrospective cohort study was performed on 100 probands with an a priori diagnosis of non-Usher SRDs, using available clinical data, including Human Phenotype Ontology annotation, and further classification into seven clinical categories (ciliopathies, specific syndromes and five others). Retrospective molecular diagnosis was assessed using different molecular and bioinformatic methods depending on availability. Subsequently, uncharacterized probands were prospectively screened using other NGS approaches to extend the number of analyzed genes. After phenotypic classification, ciliopathies were the most common SRD (35%). A global characterization rate of 52% was obtained, with six cases incompletely characterized for a gene that partially explained the phenotype. An improved characterization rate was achieved addressing prospective cases (83%) and well-recognizable syndrome (62%) subgroups. The 27% of the fully characterized cases were reclassified into a different clinical category after identification of the disease-causing gene. Clinical-exome sequencing is the most appropriate first-tier approach for prospective cases, whereas whole-exome sequencing and bioinformatic reanalysis increases the diagnosis of uncharacterized retrospective cases to 45%, mostly those with unspecific symptoms. Our study describes a comprehensive approach to SRDs in daily clinical practice and the importance of thorough clinical assessment and selection of the most appropriate molecular test to be used to solve these complex cases and elucidate novel associations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available